MedicaidPrior AuthMedium impact
KMAP BULLETIN: RESCINDED - High Dollar Rare Disease Drug List February 2024
Kansas Medicaid (KanCare)·KS · Pharmacy, Oncology, Genetics +2 more·Pharmacy
Effective date
Feb 1, 2024
We identified it
Jun 21, 2026
Summary
Kansas Medicaid (KMAP) rescinded prior authorization requirements for high dollar rare disease drugs effective February 1, 2024. These drugs will now follow existing prior authorization processes for each specific drug/therapeutic rather than the special high dollar list requirements.
Action Required
Immediately: Billing team should review current high dollar rare disease drug claims that may have been held for the rescinded prior authorization requirements. Update billing workflows to follow existing drug-specific prior authorization processes instead of the February 2024 high dollar list. Monitor KanCare MCO implementation status via the KMAP Open Claims Resolution Log for any reprocessing opportunities.